Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
changed from Pfizer to Moderna for her 3rd or 4th vaccine and she was sick, she felt sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (changed from Pfizer to Moderna for her 3rd or 4th vaccine and she was sick, she felt sick) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (Dose 2) and Pfizer (Dose 1). Past adverse reactions to the above products included No adverse effect with Pfizer and Pfizer. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (changed from Pfizer to Moderna for her 3rd or 4th vaccine and she was sick, she felt sick). At the time of the report, ILLNESS (changed from Pfizer to Moderna for her 3rd or 4th vaccine and she was sick, she felt sick) outcome was unknown. No concomitant medications were reported. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-790468 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790468:Caller's case